Turkish Journal of Gastroenterology
Gastrointestinal Tract - Original Article

Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study

1.

Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China

2.

Laboratory of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China

Turk J Gastroenterol 2020; 31: 848-852
DOI: 10.5152/tjg.2020.19507
Read: 362 Downloads: 233 Published: 04 May 2020

Background/Aims: This retrospective study aimed to evaluate the effect of low-dose aspirin (50-150 mg/d) on the severity of ischemic colitis.

Materials and Methods: A total of 244 patients admitted to our hospital for ischemic colitis between 2013 and 2018 were included in the study. Patients were divided into two groups—aspirin and non-aspirin groups—based on their recent history of aspirin use before the onset of ischemic colitis. Clinical performance, biochemical indices, and endoscopic findings were compared.

Results: The average age and the proportion of underlying disease, including hypertension, cerebral infarction, and coronary heart disease in the aspirin group was significantly higher than those in the non-aspirin group (p<0.05). In terms of clinical symptoms, the proportion of diarrhea in the aspirin group was significantly higher than that in the non-aspirin group, while the proportion of abdominal pain was significantly lower in the aspirin group compared with the non-aspirin group. Colonoscopy results showed that the incidence of ulceration was significantly higher in the aspirin group than in the non-aspirin group (p<0.05).

Conclusion: The use of low-dose aspirin may aggravate the severity and mask the symptoms of abdominal pain in ischemic colitis.

Cite this article as: Xiao W, Zhou Y, Wu K, et al. Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study. Turk J Gastroenterol 2020; 31(12): 848-52.

Files
EISSN 2148-5607